Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase Inhibitors

We sought to evaluate the outcomes of chronic phase (CP) chronic myeloid leukemia (CML) in an era where five tyrosine kinase inhibitors (TKIs) are commercially available for the treatment of CML. Records of patients diagnosed with CP CML, treated with TKIs and referred to our center were reviewed. B...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Jee Hyun, Winton, Elliott F., Heffner, Leonard T., Gaddh, Manila, Hill, Brittany, Neely, Jessica, Hatcher, Angela, Joseph, Meena, Arellano, Martha, El-Rassi, Fuad, Kim, Audrey, Khoury, Jean Hanna, Kota, Vamsi K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290862/
https://www.ncbi.nlm.nih.gov/pubmed/32443762
http://dx.doi.org/10.3390/jcm9051542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290862/
https://www.ncbi.nlm.nih.gov/pubmed/32443762
http://dx.doi.org/10.3390/jcm9051542

Ejemplares similares